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It appears justified to conclude from the studies of Weigl (1), and 
from our own work with Castaneda, that active immunization against 
typhus fever with killed Rickettsiae  can be achieved, provided a suffi- 
cient  accumulation  of  the  organisms  can  be  obtained  for  vaccine 
preparation.  Such mass production  of Rickettsiae  is  also  an  indis- 
pensable preliminary for the immunization of horses, donkeys, or goats 
in the preparation of sera for temporary prop.hyla~ds  and for thera- 
peutic application in man.  1  With the routine strains of typhus, as we 
have reported in preceding papers  (2), such Rickettsia  accumulation 
has been achieved by a number of methods, all of which depend upon 
the  intraperitoneal  infection  of  rats  in  which  resistance  had  been 
reduced by a variety of methods.  All such attempts, even the use of 
preliminary X-ray radiation of the animals (the most satisfactory of 
the methods employed), have completely failed when the European 
virus  is used.  Indeed, our persistent  failures in this regard are one 
of  the  most  convincing reasons  for  our  belief, elsewhere  set  forth, 
that  the  agents of the  routine  and  European infections--so closely 
related  in  many  of  their  attributes--are  nevertheless distinct  and 
biologically fixed varieties, not permanently convertible one into the 
* Guggenheim Fellow. 
In this respect, the situation appears to be not unlike that revealed by recent 
investigations for virus immunization--namely, that for the production of any 
degree of immunity with killed virus, large quantities of the material are required. 
It is not impossible that this point of similarity between infectious agents other- 
wise so far apart in biological attributes may be related to the tendency for intra- 
cellular localization which characterizes the pathogenic behavior of both. 
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other  by  temporary environmental or  experimental manipulations. 
These matters have been discussed by one of us in another place (3). 
The important practical consideration which follows from our observa- 
tions is  the  fact  that  for  homologous vaccine production with  the 
European Rickettsiae,  the rat technique is of no value. 
In regard to the methods at present available  for artificial immu- 
nization against the  European disease, it  appears  quite likely that 
Weigl's phenol-killed louse vaccine is effective in producing a demon- 
strable degree of immunity.  But Weigl's vaccine production necessi- 
tates the passage of the virus through large numbers of lice and appears 
obviously unsuited to the mass immunization desirable for practical 
purposes in times of epidemic spread.  Our own vaccines prepared 
with the murine strain from rats can be produced in quantity and do 
protect guinea pigs to a measurable degree from European infection. 
But the protection is not as complete as similar vaccination against 
the homologous strain.  There is also  some protective action  (pos- 
sibly also some therapeutic effect) of the antimurine serum against the 
European infection.  Guinea pig experiment has demonstrated this 
(4).  But the few human cases of the European disease treated with 
this serum do not justify even a  preliminary opinion.  That  there 
should be some overlapping in these respects is to be expected from 
the  cross immunity observed in animals which have recovered from 
infection with the respective viruses and from the serological over- 
lapping observed by one of us with Castaneda (5).  But in view of the 
seriousness of the endemic and epidemic problems of the European 
disease, it would nevertheless be of the greatest practical importance 
were it possible to develop a method applicable on a  large scale and 
not too complicated, for homologous  immunization with the Rickettsiae 
of the European disease. 
In endeavoring to find other methods of approach to the problem of 
active and eventually passive immunization against this disease we 
have followed two directions of study:  1.  The development of tissue 
culture vaccine.  2.  Serovaccination. 
1.  Tissue Culture  Vaccines 
In preparing tissue cultures of the European Rickettsiae,  we have 
followed with little  modification the  Maitland  method  successfully HANS  ZINSSER  AND  ATTILI0  MACCHIAVELLO  675 
adapted to this  purpose by Nigg and Landsteiner (6).  In attempting 
to improve this method a  considerable  amount of work has been done 
which may be briefly  summarized, since it may  serve to save time for 
others working along similar lines. 
Rickettsiae are extremely selective in regard to the tissue.  No growth has been 
obtained when guinea pig kidney, liver, brain,  or heart  muscle  was  substituted 
for tunica scrapings.  Slight  growth was obtained with  scrapings  of the  lining 
cells  of  the  peritoneum.  Rabbit  tissues  have  given  negative  results.  Chick 
embryo likewise. 
It  was  at  first  thought  that  guinea  pig  serum  was  essential.  We  have 
recently found, however, that one part in four of either horse serum or human 
serum mixed with Tyrode solution before filtration give~ even better growth than 
the guinea pig-serum Tyrode mixtures.  It is  still  to  be determined whether 
there is active metabolism as determinable by oxygen consumption on the part 
of the guinea pig tissue in horse serum and human serum mixtures.  No growth 
has been obtained in Tyrode solution without serum.  Filtered  ascitic fluid, sub- 
stituted for Tyrode solution,  if free  from bile, gives much heavier  growth than 
the  Tyrode-serum mixtures,  though individual ascitic fluids vary. 
Like Nigg and Landsteiner,  we have found that the cultures  remain  virulent 
and Rickettsiae survive when the flasks are stored without removal of the stoppers. 
In this manner, a  tissue  culture of the Mexican  strain has been found virulent 
after  7½ months and a  European culture  for 4½ months.  One of our students, 
Dr. C. J. Wu, took a sealed murine  culture  to China,  without precautions  of re- 
frigeration,  and writes us that he obtained successful inoculation on arrival. 
The Rickettsiae will not grow on tunica tissue heated to 50°C. for 15 minutes. 
Nigg and Landsteiner  (7)  reported occasional  slight  temperature  reactions  and 
immunization  in guinea  pigs after the inoculation  of a  third generation  culture 
on tissue thus heated,  although no Rickettsiae could be seen in the material inocu- 
lated.  They reported  the  facts without drawing  conclusions, but  Laigret and 
others have taken this to indicate  the presence  of an invisible  form of typhus 
virus,  perhaps  in cyclic relation  with the Rickettsiae.  We have repeated  these 
experiments  a number of times and have in no case obtained either temperature 
reactions  or subsequent  immunity in guinea pigs inoculated  with materials  from 
the second or third heated tissue culture generations.  We venture to suggest that 
Nigg  and  Landsteiner's  results  may  have  been  due  to  the  survival of a 
few Rickettsiae carried over from flask to flask. 
Although tissue  in  such  cultures  ceases  to respire  after  about  40 hours,  as 
measured  in the Warburg apparatus, and the viability of the cells is unlikely  to 
last longer  than a  week,  the most active proliferation  of Rickettsiae appears  to 
take place after the 4th day.  An equilibrium of some kind seems to be established 
which creates conditions favorable for growth.  These conditions, as far as respira- 
tion, reaction, and oxidation-reduction  potentials  are concerned, are being investi- 676  Tx~m~s  YEVER 
gated.  Assuming the establishment  of such an equilibrium,  uninoculated  tissue 
cultures  were preserved  in the incubator for a varying number of days and then 
inoculated, but no successful cultures were thus obtained. 
Efforts  are being  continued  to  adapt  the  Nigg and  Landsteiner  method  to 
larger quantitative yields by the use of specially designed flasks.  It appears that 
for  successful  cultivation  a  definite relationship  between  the square  surface ex- 
posed by the fluid and the cubic air space of the closed flasks must be maintained. 
For the present  studies our methods of tissue  culture vaccine pro- 
duction have not varied--except for the frequent substitution of ascitic 
fluid for Tyrode solution, from the Nigg-Landsteiner procedure. 
The source of the culture virus--in three separate  isolations, was the material 
obtained by mincing or b'y scraping  the tunica vaginalis  of guinea pigs injected 
intraperitoneaUy  with large  doses of blood  and brain mixtures  from previously 
infected animals.  Such guinea pigs show, in about 20 per cent of the inoculated, 
slight scrotal swelling with a few Rickettsiae in cell smears.  The cultivated strains 
have been carried on in our laboratory for about 2 years. 
The optimum time for the harvesting of such cultures lies between the 8th and 
the 10th days. 
The production of the vaccines has been more or less the same as that employed 
for the same purpose by Kligler and Aschner (8).  Culture  flasks are pooled and 
centrifugalized.  The supernatant fluid--in which the numbers  of organisms are 
negligible--is  discarded.  The bits of tissue are shaken in salt solution containing 
0.2  per cent formalin.  This removes  most of the  obtainable  Rickettsiae.  The 
tissue is again thrown down in the centrifuge and can be further disintegrated  by 
freezing  and  thawing  in  a  beaker  of  solid  carbon  dioxide  in  ethylene-glycol- 
monomethyl ether--the sohtion used with the Florsdorf-Mudd  apparatus.  This 
is done in pointed centrifuge tubes accompanied by grinding.  The ground tissue 
is added to the washings previously  obtained.  Standardization  of such vaccine 
has so far been impossible on any basis sufficiently accurate to justify description. 
The amounts of vaccine employed are based on the assumption  that the cultures 
contain approximately  equivalent  numbers  of Rickettsiae.  1 cc. represents  the 
yield of about one-fifth of a small (25 cc.) flask, containing  a total volume of 2.5 
to 3 cc. of culture fluid. 
With such vaccines, we have  carried out a  number of immunization 
experiments.  All vaccine injections were subcutaneous.  The  results 
of our first fifteen vaccinations were as follows: 
One Injection of Vaecinv.--A single vaccine injection of 1 cc.  Immunity test 1 
month later,  with brain virus.  Temperature touching 104°F. on 8th,  9th, and 
10th days.  Mild typhus. I:IAIgS ZIIqSSER  AND  ATTILIO  MACCHIAVELLO  677 
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Crt~x  1.  The  results  of  the  subcutaneous  injection  of  formalinized tissue 
culture vaccine in three different types of experiment.  The arrows indicate the 
time  of vaccine  injections and  the  amounts.  The  broken  lines  represent  the 
results of immunity tests carried out by intraperitoneal inoculation of doses of 
European  brain virus, which gave severe typhus in  controls.  In  curve  1,  the 
immunity test was carried out 33 days after vaccination; in curve 2, 28 days, and 
in curve 3, 37 days after vaccination.' 678  T~H~S  Fv.Wa 
Two guinea pigs.  A single vaccine injection of 2 cc.  Immunity test  1 month 
later.  No typhus. 
Two Injections of Vaccine.--Five  animals were given two vaccine injections, 
5 days apart,  1 co. at each injection.  Three of these animals were reinjected 
after 2 months with heavy doses of brain virus (3 to 5 cc.).  All showed mild 
typhus temperature curves, rising above the critical point of 104°F. for 2, 3, and 
4 days respectively.  There was apparently a moderate increase of resistance but 
no immunity. 
The other two were similarly reinfected 6 weeks after vaccination and were 
found immune. 
Three Injections  of Vaccine.--Eight  animals received three injections of the 
culture vaccine, the intervals varying in the individual experiments from 3 to 4 
days.  In three of these guinea pigs the dosages were 0.5 co. at each injection. 
In others the doses were 1 co. each and in four animals the doses were 0.5 cc., 
1.0 cc., and  1.5 cc. respectively.  Intervals between vaccination and immunity 
tests were from 30 to 38 days.  All of these animals were found immune when 
reinoculated with virus controlled and found potent  in normal animals. 
Chart 1 shows the results of tissue culture vaccination in a number of 
animals. 
From these experiments it is clear that, as Kligler and Aschner have 
reported, it is quite possible to obtain effective active immunization in 
guinea pigs  against  the  dassical  European  virus  with formalinized 
homologous tissue culture vaccines.  The experiments further indicate 
that such immunity may last at least a  month and that successful 
vaccination requires a definite minimum of killed Rickettsia material. 
That a single sufficiently large dose of virus may suffice is indicated in 
Chart 1.  The best results were obtained when three separate injec- 
tions of vaccine were administered. 
2.  Serovaccination 
While it is always preferable to make use of killed rather than of 
living  infectious  agents  for  immunizations which  are  intended  for 
eventual application to diseases of man, it has, nevertheless, appeared 
important to us to explore all the possibilities which offer some hope 
of practical solution of such large scale problems as those involved in 
epidemics of European typhus fever. 
Our attention was turned to serovaccination by an incidental obser- 
vation made by one of us, with Batchelder, in 1930 (9).  At that time, 
a  guinea pig which had been used for neutralization tests of conva- HANS  ZINSSER  AND  ATTILIO  MACCHIAVELLO  679 
lescent guinea pig serum against homologous (routine) virus and found 
fully protected, was  reinoculated several weeks later,  and failed to 
exhibit any symptoms of typhus. 
Serovaccination has given encouraging results in  the past  in  the 
immunization of  animals  against  a  variety  of  diseases  caused  by 
filtrable virus agents and, within recent years, has been successfully 
employed in the case of yellow fever, by Sawyer and his collaborators 
(10).  To be sure our own experience with herpes, where fully neutral- 
ized virus invariably failed to induce even a partial immunity, was not 
encouraging.  But here, as in poliomyelitis, the immunological prob- 
lem is  complicated by  the  unsolved difficulties involved in  neural 
transport  and  in  the  blood-brain  barrier.  Between  those  virus 
diseases, in which these factors do not enter into consideration, and 
the  Rickettsia  diseases, there  is a  considerable immunological simi- 
larity, possibly because of the analogous intracellular localization of 
the responsible infectious agents. 
Basing our efforts on these considerations and on the observation 
cited above, we accordingly proceeded to treat series of guinea pigs 
with a  variety of adjusted mixtures of European typhus virus and 
protective sera,  employing combinations of the two in the following 
forms. 
1.  Virus in the form of infectious defibrinated guinea pig blood, or of 
virulent guinea pig serum, plus convalescent guinea pig serum taken 
4 or 5 days after defervescence. 
2.  Similar  defibrinated  blood,  plus  antimurine  (heterologous) 
immune horse serum. 
3  and 4.  Virulent brain suspension with each kind of serum re- 
spective!y. 
5 and 6.  Tissue culture virus with each kind of serum respectively. 
The technique, except in those cases in which brain virus was used, 
consisted in the preparation of measured mixtures of virus and serum, 
allowing these to stand for 10 minutes at room temperature, and then 
injecting intraperitoneally. 
A major difficulty encotmtered in some of these studies was the fact 
that our original typhus horse, which had been yielding a potent anti- 
typhus serum, died at  this time and all our stocks of active serum 
contained preservatives.  The new horse was delivering a  serum of 680  TYPHUS FEVER 
which the Well-Felix reaction had not yet exceeded a titer of 1 to 80 
(+ +-}--{-), 1 to 160 (-{-).  With a stronger serum it might have been 
possible to make more accurate adjustments and this, of course, will 
be done later. 
Experiments in which infectious brain was used as virus were on the 
whole  unsatisfactory because,  as  we  have  reported  in  a  preceding 
publication,  in  order  to  protect  against  brain  virus  in  which  the 
injected Rickettsiae  are presumably intracellular,  it  is  necessary to 
administer the protective serum in  several injections from 24  to 48 
hours after inoculation of the virulent material.  The probable reasons 
for this have been discussed elsewhere (4).  By following this tech- 
nique it has indeed been possible, in two experiments of the present 
series, to immunize guinea pigs by inoculations of brain virus com- 
pletely neutralized by serum given 24 and 48 hours later as indicated. 
This method is, however, less certain and more complicated than other 
procedures to be reported. 
Two early experiments gave no information because we used doses of 
virus so small that even the control animals failed to show the usual 
symptoms of experimental typhus infection. 
As  the  amounts  of  virus  were  increased  to  points  at  which the 
unprotected controls showed late and short lived typhus reactions, the 
serovaccinated  animals,  fully protected  as  regards  the  vaccination 
mixtures, did not prove to be immune.  (Two experiments.)  It was 
obviously necessary, for  successful serovaccination, to  make use  of 
mixtures which contained enough virus to produce vigorous experi- 
mental typhus in the controls. 
In subsequent experiments, therefore, the amounts of virus in the 
mixtures were so adjusted that the control animals in which normal 
serum and salt solution were used, reacted with a severe and prolonged 
experimental  typhus.  When  this  technique  was  employed  the 
results were of two types which we may designate as complete and 
partial,  these terms referring to  the degrees of neutralization of the 
original mixtures. 
In the complete experiments, of which there are four to date, the 
animals receiving the serum-virus mixtures remained entirely normal 
as far as the usual criteria of experimental typhus are concerned, while 
the normal serum and  salt  solution virus  controls reacted severely. t. 
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CHART 2.  In this experiment serovaccination was carried out on four guinea 
pigs with mixtures containing, respectively, 0.5 cc. of tissue culture virus (repre- 
senting about  0.1  cc.  of a  tissue culture)  and  !  cc.  of convalescent guinea pig 
serum, taken from an animal that had passed through a typical European typhus, 
on the 4th day after defervescence.  The mixtures were allowed to stand for 10 
minutes at room temperature and injected intraperitoneally. 
In this chart, the first curve represents one of three serovaccinated animals. 
One only is charted, since they were all alike and it was considered particularly 
important to chart all the controls.  In all the curves, the solid blocks represent 
temperatures above  104°F.  The broken lines represent the  temperatures after 
reinoculation with virulent brain emulsion for immunity test.  Curve 2 represents 
the normal serum conti:ol.  Curve 3 represents the salt solution control.  Curve 4 
is the control of the brain virus used for immunity test 1 month after the sero- 
vaccination. 
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CHART 3.  In  this  experiment,  two  guinea  pigs received  1.5  cc.  of  virulent 
defibrinated guinea pig blood mixed with 0.5 cc. of the serum of our second horse, 
which was being immunized with  murine  (heterologous) RickeUsiae obtained by 
the  X-ray rat  method.  For reasons  stated above,  the  Well-Felix titer of this 
serum did not exceed 1-80 at  the time of this experiment.  The mixtures were 
allowed to stand for 10 minutes  at  room temperature  and injected  intraperito- 
neally.  One only of the serovaccinated animals is charted, since both were essen- 
tially alike in result and it appeared important to chart the controls completely. 
Temperatures  above  IlN°F. are  blocked in  black.  Broken  lines represent  the 
results of immunity tests carried out with virulent brain emulsion of European 
typhus, intraperitoneally injected 2 months after serovaccination.  Curve 2 is the 
vaccination control in which the virulent blood was mixed with 0.5 cc. of normal 
horse serum.  Curve  3  is the  saline  control of  the  virus used  for  the  original 
vaccination.  Curve 4 proves the virulence of the virus emplbyed for reinoculation. 
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The test animals proved immune when reinoculated with large doses 
of virus a  month or so later.  Charts 2 and 3 illustrate such experi- 
ments. 
In the partial experiments, of which four have been completed at the 
present time, the relative amounts of virus and of serum in the vac- 
cinating mixtures were such that there was a slight excess of virus over 
neutralizing power.  From the practical point of view these experi- 
ments seem to us of considerable importance in that they show that 
even  when  complete  neutralization  is  not  achieved  in  the  experi- 
mentally difficult adjustment between the two reacting factors,  the 
severity of the infection is  almost  always mitigated,  sufficiently to 
prevent serious infection.  A simple table will serve to illustrate these 
conditions as follows: 
Type of serovaccination 
1.  Virus  defibrinated  guinea  pig 
blood 2 cc. 
Immune horse serum 0.5 cc. 
2.  Tissue culture virus 0.1 cc. 
Convalescent guinea pig serum 
0.5 cc. 
3.  Tissue culture virus 0.1 cc. 
Immune horse serum 0.5 cc. 
4.  Tissue culture virus 0.0S cc. 
Convalescent guinea pig serum 
1 cc. 
Serovaccinated 
Incubation  Duration of  fever 
days  days 
16  I 
16  2 
11  4 
11  2 
11  2 
No fever whatever 
11  [  1 
11  1 
Two  "spikes"  of 
temperature  on 
4th and 14th days 
13  1 
11  4 
11  4 
Normal serum and virus 
controls 
Incubation  Duration of  fever 
days  days 
7  10 
8  8 
5  10 
5  8 
3  10 
5  8 
6  7 
3  10 
3  11 
A  chart of one of these partial experiments further illustrates these 
conditions (Chart 4). 
It  is  clear from the experiments  recorded  that  guinea  pigs  can 
be immunized against  European typhus virus by preliminary injec- 
tions of mixtures of living virus and protective serum so adjusted that 684  Tx~m2s  ~wR 
no experimental typhus results from the injections.  It has further 
been shown that when the perfect balance between the two  active 
factors is not achieved and a moderate excess of virus is present, the 
serum almost invariably reduces the severity of the infection. 
An important question arises in connection with the serovaccination 
experiments in regard to the fate of the living virus injected in such 
cases.  It is quite conceivable that although such virus is neutralized 
by the  serum with which it  is mixed and thereby prevented from 
causing experimentally determinable infection, it might still remain 
e~ 
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C~..ART 4.  One of the partiM serovaccination experiments.  The temperature 
curve represented  in broken lines is that of a  guinea pig which received, intra- 
peritoneally, O.I cc. of tissue culture virus mixed with  1 co. of homologous con- 
valescent guinea pig serum.  That charted in solid lines represents the reaction 
in a guinea pig injected with the same amount of virus mixed with normal guinea 
pig serum. 
alive and convert the vaccinated animals into carriers.  The impor- 
tance of such a possibility in connection with any attempts to apply 
serovaccination to man is obvious.  In attempting to approach this 
problem experimentally we have injected large quantities of brain and 
blood  (½ brain plus 4  cc. of defibrinated blood)  from a  successfully 
serovaccinated animal, killed on the 24th day after the vaccination, 
into other guinea pigs.  The animals so injected showed no reactions 
whatever.  Such tests will require elaboration and, whatever the out- 
come, it must be borne in mind that in this regard particularly no 
generalization from guinea pig experiment to man is permissible. HANS  ZINSSER  AND  ATTILIO  MACCHIAVELLO  685 
DISCUSSION 
Although the manner of transmission and the r61es played by in- 
sects and by rodents in the dissemination of the typhus fevers is fairly 
well understood, experience has shown that sanitary measures alone 
do not, as yet, suffice to control these diseases when circumstances 
favor epidemic spread.  The situation would be materially improved 
were methods available for specific prophylaxis applicable to infected 
populations on an adequate scale.  In the case of the Mexican (mu- 
r!ne) type, vaccine and serum production by methods which depend 
upon the accumulation of Ricket~sia~ in rats in which resistance has 
been experimentally reduced have been elsewhere described and are 
giving encouraging results.  But while these murine products exert a 
certain degree of overlapping protective action on infection with the 
European virus, their effects in this respect are partial and imperfect. 
While, in our opinions, the Weigl louse vaccine is about as effective 
as any that  can be at present obtained, it is quite unlikely that  a 
vaccine of this kind can ever be produced in quantities large enough 
to be of practical importance in epidemics. 
The experiments above recorded have confirmed the effectiveness of 
formalinized European tissue culture vaccines in the guinea pig experi- 
ment.  Such vaccines can be produced on a  reasonable scale by a 
trained  staff  in  a  well equipped  laboratory.  Judging from  a  now 
extensive experience with injections of formalinized murine vaccines 
into man, human application of the tissue culture vaccines, with proper 
sterility control, would seem to be without danger.  Our own efforts 
at present are being exerted toward the development of methods for 
increased quantity production, in observations on the duration of the 
active immunity obtained in guinea pigs and on the storage periods 
for which the vaccines will remain potent.  In the meantime, by the 
now available methods, sufficient amounts of the tissue culture vac- 
cines can be freshly produced for thorough testing in man. 
It is not likely, however that, until one succeeds in increasing quan- 
tity production and in simplifying Rickettsia  tissue culture methods, 
these vaccines can be freshly produced in amounts adequate to meet 
the serious emergencies of typhus epidemics.  It is this consideration 
which has encouraged our interest in serovaccination.  That such a 
method can be applied effectively is shown by our experiments.  It is 686  TYPHUS :FEVER 
equally obvious, however, that as yet it is quite impossible to set up 
any standard which will insure against moderate excess of virus over 
serum potency.  Nevertheless, the materials for certain types of sero- 
vaccination (guinea pig blood and guinea pig convalescent serum) can 
be made available in considerable amounts with almost no equipment. 
The method is therefore at least worthy of further study for possible 
application in the face of destructive epidemics.  Our efforts to over- 
come some of the difficulties involved in the adjustment of virus and 
serum  for  serovaccination, by  the  desiccation  of  tested  virus  and 
virus-serum mixtures in  vacuo by the Florsdorf-Mudd method, have 
thus far failed.  Such failure has been due to the deterioration of the 
European virus under these conditions, within 50 days, a period during 
which the murine virus,  similarly desiccated, appears to  retain full 
potency.  These experiments are being continued. 
S~RY 
1.  Guinea pigs can be actively immunized against European typhus 
fever with  homologous formalinized Rickettsia  tissue  cultures,  pro- 
vided sufficient amounts are injected.  The method is suggested for 
practical application in man. 
2.  Serovaccination against European typhus fever can be success- 
fully applied to guinea pigs by a variety of methods, the simplest of 
which consists of the injection of mixtures of virulent defibrinated 
guinea pig blood and convalescent guinea pig serum taken from 3 to 5 
days after defervescence.  Similar results can be obtained with mix- 
tures in which tissue culture virus, either with convalescent guinea pig 
serum or with antimurine horse serum, is  used.  There is no indica- 
tion so far that such animals become carriers. 
Possible  application  of  these  methods  to  typhus  epidemics  is 
discussed. 
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